Company intelligence / Profile preview
Repare Therapeutics
Cambridge, Massachusetts, United Statesreparerx.com ↗
- Ownership
- Public · RPTX
- Employees
- ~34
- Development stage
- Phase 1
01
Overview
The company has multiple clinical programs with promising results. Their lunresertib and camonsertib combination showed positive results in Phase 1 trials for endometrial and ovarian cancer patients, with overall response rates of 25.9% and 37.5% respectively. The company has reprioritized its pipeline to focus on RP-1664 and RP-3467, with data from the POLAR trial expected in Q3 2025.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Previously partnered with Roche (terminated in May 2024)DCx Biotherapeutics (out-licensing of discovery platforms announced May 1, 2025)
04
Financials
- Market cap
- $114.2M
- Total revenue
- $11.6M
- Enterprise value
- $2M
Beyond the preview
Go deeper on Repare Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Repare Therapeutics.